[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"focus-on-axial-length\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:focus-on-axial-length":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100628042",false,"NCT07456488","The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group","Inclusion Criteria:\n\n* Children aged 4-16 years\n* Both genders\n* Myopia of baseline SER of -1.00D or more\n* Astigmatism less than or equal to -2.50D\n* No medical history predisposing severe myopia (e.g., Marfan syndrome, Stickler syndrome, and retinopathy of prematurity), abnormal ocular refractive anatomy (e.g., keratoconus, lenticonus, and spherophakia)\n* No history of other vision-threatening ocular diseases or previous intraocular surgery.\n* No current or previous use of atropine or pirenzipine, contact lenses or other forms of treatment that may affect myopia progression.\n\nExclusion Criteria:\n\n* Astigmatism ≥ 2.5 D\n* Anisometropia\\>1 D\n* Best corrected visual acuity \\\u003C 0.5 (6\u002F12)\n* Prior intraocular surgery\n* Allergy to atropine eye drops\n* Systemic diseases associated with myopia such as Marfan syndrome, Stickler syndrome\n* History of cardiac or significant respiratory diseases\n* Lack of consent for participating in the study","ALL","4 Years","16 Years",{"count":18,"type":19},60,"ESTIMATED","INTERVENTIONAL",[22],"PHASE2","In this study, atropine 0.01% eye drops will be given to myopic children once at night daily for 6 months as compared to a control group to see the effect on axial length and refraction",[25],"Focus on Axial Length","RECRUITING","2026-03-03",{"date":29,"type":30},"2026-03-06","ACTUAL",{"date":32,"type":30},"2025-07-13",{"date":34,"type":19},"2026-04-30",{"name":36,"class":37},"Liaquat National Hospital & Medical College","OTHER",""]